Riskpilot← Back to searchSign inGet full accessROSE MIDCO AS
ASActiveOrg 931050761Haakon Viis Gate 1, 0161 OsloMedical specialists activities · NACE 8622Est. 20230 employees
Revenue 2024
NOK 0
EBITDA margin
—
-314% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -114K
-333% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -146K | -314% |
| Net profit | NOK -114K | -333% |
| Total assets | NOK 343,2M | +10% |
| Equity | NOK 343M | +10% |
| Employees | 0 | — |
Legal name
ROSE MIDCO AS
Org number
931050761
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
17. mars 2023
Share capital
NOK 556 998
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Å eie aksjer og investere i andre selskaper.
Address
Haakon Viis Gate 1, 0161 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | −0 | −0 |
| EBITDA | −35 | −146 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −35 | −146 |
| Net financials | 0 | 0 |
| Profit before tax | −35 | −146 |
| Tax | −9 | −32 |
| Net profit | −26 | −114 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 313 187 | 343 192 |
| Equity | 313 156 | 343 042 |
| Long-term debt | 0 | 0 |
| Short-term debt | 31 | 150 |
| Total debt | 31 | 150 |
EBITDA margin
-14639800.0%
This company
15.8%
Market median
-92657062% vs market
20232024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20232024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20232024
Net profit margin
-11413100.0%
This company
8.1%
Market median
-140902569% vs market
20232024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20232024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-02-28 – 2023-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Rose Investco As | Company | 52.4% | 52.4% | 2024 |
Karuna Holding As | Company | 13.5% | 13.5% | 2024 |
Promedica As | Company | 13.0% | 13.0% | 2024 |
Runa As | Company | 6.3% | 6.3% | 2024 |
Skeiseid-Klefstad Holding As | Company | 4.1% | 4.1% | 2024 |
Going Holding As | Company | 3.8% | 3.8% | 2024 |
Finn T. Johnsen Holding As | Company | 3.7% | 3.7% | 2024 |
Line Medical Ii As | Company | 3.3% | 3.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Runa As
ROSE MIDCO AS Board members of ROSE MIDCO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Toft Bysveen | Chairman | 0 companies |
| Terje Sørdal | Board of Directors | 0 companies |
| Kristian Brekke Djuve | Chairman | 0 companies |
| Fredrik Lundervold Kongsli | Board of Directors | 0 companies |
| Morten Faye Eriksen | Board of Directors | 0 companies |
| Magnus Finset Sørdal | Board of Directors | 0 companies |